Prescription patterns in preventive and abortive migraine medication

Cephalalgia

Volumn 31, Issue 16, 2011, Pages 1659-1663

  Sumelahti, Marja Liisa ^a   Mattila, Kari ^a   Sillanmäki, Lauri ^b   Sumanen, Markku ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

acute medication; Migraine; prescription practice; prophylactic medication

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ERGOTAMINE DERIVATIVE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; POPULATION RESEARCH; PRESCRIPTION; PROPHYLAXIS; REGISTER; SOCIAL INSURANCE;

ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; FINLAND; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; TRYPTAMINES; YOUNG ADULT;

EID: 83755221057     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411427602     Document Type: Article

References (28)

1. Lipton RB, Bigal ME, Diamond M, et al. (AMPP advisory group). Migraine prevalence, disease burden and the need for preventive therapy. Neurology 2007; 68: 343-349. (Pubitemid 46184209)
2. Krobot KJ, Schröder-Bernhardi D and Pfaffenrath V. Migraine consultation patterns in primary care. Results from the PCAOM study 1994-96. Cephalalgia 1999; 19: 831-840.
3. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007; 47: 355-363. (Pubitemid 46426410)
4. Headache Classification Subcommittee of the International Headache Society. International Classification of Headache Disorders. 2nd ed. Cephalalgia 24 (Suppl 1): 9-160.
5. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol 2009; 16: 968-981.
6. Stewart WF, Shechter A and Lipton RB. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology 1994; 44: S24-S39.
7. MacGregor EA, Brandes J and Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003; 43: 19-26. (Pubitemid 36150986)
8. Rantala A, Sumanen M and Mattila K. Migraine among working-age population. (In Finnish, abstract in English). Yleislääkäri 2007; 4: 20-24.
9. Tepper SJ. A pivotal moment in 50 years of headache history: the first American Migraine Study. Headache 2008; 48: 730-731. (Pubitemid 351678023)
10. Statistical Yearbook of the Social Insurance Institution 2008. ISSN 1796-5667.
11. The treatment of migraine Current Care Summary 10.5.2002. The Working Group Set up by the Finnish Medical Society Duodecim and The Finnish Society of Neurology. Duodecim 2002; 118: 1200.
12. The treatment of migraine Current Care Summary 18.9.2008. The Working Group Set up by the Finnish Medical Society Duodecim and The Finnish Society of Neurology. http://www.terveysportti.fi/xmedia/hoi/hoi36050.pdf.
13. Krobot KJ, Steinberg HW and Pfaffenrath V. Migraine prescription density and recommendations. Results of the PCAOM study. Cephalalgia 1999; 19: 511-519. (Pubitemid 29309042)
14. Sumanen M, Rantala A, H Sillanmäki L, et al. Childhood adversities experienced by working-age migraine patients. J Psychosom Res 2007; 62: 139-143. (Pubitemid 46161584)
15. Korkeila K, Suominen S, Ahvenainen J, et al. Nonresponse and related factors in a nation-wide health survey. Eur J Epidemiol 2001; 17: 991-999.
16. Heinrich M, Morris L and Kröner-Herwig B. Self-report of headache in children and adolescents in Germany: possibilities and confines of questionnaire data for headache classification. Cephalalgia 2009; 29: 864-872.
17. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology 2003; 61: 375-382. (Pubitemid 36975969)
18. Ng-Mak DS, Cady R, Chen YT, et al. Can migraineurs accurately identify their headaches as 'migraine' at attack onset. Headache 2007; 47: 645-653. (Pubitemid 46733714)
19. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002; 58: 885-894. (Pubitemid 34242063)
20. Koch HJ and Jürgens TP. Antidepressants in long-term migraine prevention. Drugs 2009; 69: 1-19.
21. Lafata JE, Tunceli O, Cerghet M, et al. The use of migraine preventive medications among patients with and without migraine headaches. Cephalalgia 2010; 30: 97-104.
22. Kattainen A, Salomaa V, Härkänen T, et al. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J 2006; 27: 296-301. (Pubitemid 43100024)
23. Hoffmann J and Reuter U. Treatment of migraine. Dtsch Med Wochenschr 2007; 132: 2153-2158. (Pubitemid 350032506)
24. Bigal ME, Borucho S, Serrano D, et al. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia 2009; 29: 891-897.
25. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001; 41: 638-645. (Pubitemid 32777746)
26. Bigal ME and Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology 2008; 71: 1821-1828.
27. Scher AI, Lipton RB, Stewart WF, et al. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 2010; 30: 321-328.
28. Bigal ME, Borucho S, Serrano D, et al. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia 2009; 29: 891-897.